Assessment of independent effect of olanzapine and risperidone on risk of diabetes among patients with schizophrenia: population based nested case-control study.
about
Off-label psychopharmacologic prescribing for children: history supports close clinical monitoringAntipsychotic drug treatment for elderly people with late-onset schizophreniaAntipsychotic drug treatment for elderly people with late-onset schizophreniaOlanzapine alone or in combination for acute maniaMinireview: the case for obesogensEndocrine disrupters as obesogensWorld Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, Part 1: acute treatment of schizophrenia.Metabolic risk factor profile associated with use of second generation antipsychotics: a cross sectional study in a Community Mental Health CentreModern antipsychotic drugs: a critical overviewRisk of diabetes mellitus associated with atypical antipsychotic use among Medicaid patients with bipolar disorder: a nested case-control study.Approach to managing behavioural disturbances in dementia.Psychiatric disorder in early adulthood and risk of premature mortality in the 1946 British Birth Cohort.Weight gain and new onset diabetes associated with olanzapine and risperidone.Relationship of atypical antipsychotics with development of diabetes mellitus.Safety and tolerability of atypical antipsychotics in patients with bipolar disorder: prevalence, monitoring and management.The assessment and management of antipsychotic-associated metabolic disturbances from a psychiatric perspective.Schizophrenia, the metabolic syndrome and diabetes.Atypical antipsychotics and diabetes mellitus.Risk:benefit assessment of old medicines.Clinical experience with aripiprazole treatment in ten elderly patients with schizophrenia or schizoaffective disorder: retrospective case studies.The role of atypical antipsychotics in glucose/insulin dysregulation and the evolving role of the psychiatrist in a new era of drug treatment options.Frequency of new-onset diabetes mellitus and use of antipsychotic drugs among Central Texas veterans.Atypical antipsychotic agents and increased risk of diabetes: class action or differential action?Influence of the drug exposure definition on the assessment of the antipsychotic metabolic impact in patients initially treated with mood-stabilizers.Pharmacological treatment strategies for schizophrenia.Ethnic differences in primary care management of diabetes and cardiovascular disease in people with serious mental illness.Olanzapine: a critical review of recent literature.Association between antipsychotic drugs and diabetes.A review of atypical antipsychotic drugs versus conventional medication in schizophrenia.The metabolic effects of antipsychotic medications.Life-threatening hyperglycemia and acidosis related to olanzapine: a case report and review of the literature.Minimising metabolic and cardiovascular risk in schizophrenia: diabetes, obesity and dyslipidaemia.Risk of treatment-emergent diabetes mellitus in patients receiving antipsychotics.Excess mortality in persons with severe mental disorder in Sweden: a cohort study of 12 103 individuals with and without contact with psychiatric services.Impact of schizophrenia and schizophrenia treatment-related adverse events on quality of life: direct utility elicitation.An economic evaluation of aripiprazole vs olanzapine adapted to the Italian setting using outcomes of metabolic syndrome and risk for diabetes in patients with schizophrenia.Treatment of schizophrenia with long-acting fluphenazine, haloperidol, or risperidoneDevelopment of diabetes mellitus associated with quetiapine: A case series.Belgian consensus on metabolic problems associated with atypical antipsychotics.Issues relating to study design and risk of bias when including non-randomized studies in systematic reviews on the effects of interventions.
P2860
Q21202071-F4C5D45E-D438-47C4-B5DA-65AE4CF2FD86Q24203649-DDA9CFD1-0A1A-4DC9-BDC1-586990D94398Q24248738-93858971-BE7D-4B76-9F12-CAC6CE61F083Q24250164-251A6461-E327-41F2-9026-8837DEE86156Q24641886-A3F6DACB-962F-4715-9B62-E922BE21092AQ24647272-C0D00788-B861-460D-84E8-0C531E5E018FQ33223628-931759D2-0D6C-4A72-8BBD-FA538C8CB9B6Q33236751-1851603E-A668-48EE-BBDD-9FB16929D478Q33853390-D1018DB2-4697-43D3-BA0D-B08885094424Q34595255-46E99BA6-B320-4954-A110-C9718D289C1CQ34683770-32FA5AF8-C0B2-4CAB-9460-58FD44D17088Q34708460-BCCEB6A7-E903-42E0-9707-CC522DD7C1B6Q34733828-42C6164F-773A-4AEA-A926-6484B4778C52Q35591014-643B32DF-FE9E-4124-85CB-75C852A75EE9Q35618441-E3F0C227-84D5-428E-96AB-5B95DE53BB1BQ35752734-85DB4ACA-9AC8-4CDA-82B1-F4AFD2611181Q35779054-2D9C4D55-8EF9-431A-A2FC-C695872D3559Q35793345-0E548850-E7F2-4DB4-AD98-67171DA94C04Q35826523-B69E35F8-F32A-4793-8C86-AA295E770AB1Q35936263-8103265D-2CCC-4A7C-A583-349A22B15F7DQ35936267-97967F4E-94FA-4319-ACD1-57B6B10C4A12Q35945454-9FFDF5D8-3B62-4B57-9049-B409842116D8Q36040749-A6DD87B0-9876-4822-913E-02578F545E40Q36088018-B2EE7AEF-8EA8-479C-BF98-1272254BDCA5Q36107179-7354AD5D-36AC-47F9-9A10-AE832B12DD92Q36113905-3CB663D9-974D-4087-B382-EAAF03148D1DQ36273449-C6DB49D6-FEEE-449A-A2AD-4B262B529723Q36382695-51AD7556-80FB-4AB8-A1E6-268F7CF6A927Q36573892-F4FE6239-AAAE-4591-A6F9-530666FA15F2Q36577856-E11A80F9-24D5-4311-861D-DA1D4467B677Q36720733-B6690C23-2C4C-463E-A49F-46F6A8FEA939Q36893286-DFD95915-31D7-4D9F-AF2E-A873B5017D28Q36929181-0E21A60C-9BBD-4470-B316-AA0AFE58C766Q36957061-38EFD2E4-3869-487E-8BEB-D7A604EF4297Q37035804-24AD51BA-2B42-4676-B724-088A541CFFAAQ37062558-F0CF61A7-4F77-4F9C-BBF5-06C8E011A39FQ37427122-971D1E5B-C4D3-4B88-9AD4-AC1608106389Q37613388-25E2C7EA-8ED6-46A7-B222-10554BB2F1C9Q38220364-B0F8F9B7-5E77-4E84-8657-DCFDE53645AFQ38520302-AB4C1383-1241-4928-B1B3-3C06C35B27CC
P2860
Assessment of independent effect of olanzapine and risperidone on risk of diabetes among patients with schizophrenia: population based nested case-control study.
description
2002 nî lūn-bûn
@nan
2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Assessment of independent effe ...... sed nested case-control study.
@ast
Assessment of independent effe ...... sed nested case-control study.
@en
type
label
Assessment of independent effe ...... sed nested case-control study.
@ast
Assessment of independent effe ...... sed nested case-control study.
@en
prefLabel
Assessment of independent effe ...... sed nested case-control study.
@ast
Assessment of independent effe ...... sed nested case-control study.
@en
P2093
P2860
P356
P1433
P1476
Assessment of independent effe ...... sed nested case-control study.
@en
P2093
Carol E Koro
Dennis A Revicki
Donald O Fedder
Gilbert J L'Italien
Julie Kreyenbuhl
Laurence S Magder
Robert W Buchanan
Sheila S Weiss
P2860
P356
10.1136/BMJ.325.7358.243
P407
P577
2002-08-01T00:00:00Z